Cary, North Carolina — Cary, North Carolina

Cary, North Carolina is a clinical research site located in Cary, North Carolina, United States 27511.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Cary, North Carolina has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO).

Sponsors: EyeBiotech Ltd..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cary, North Carolina?

Cary, North Carolina has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cary, North Carolina conducted?

Cary, North Carolina has 2 clinical trials on record, with 2 currently active. Their work covers Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO).

Is Cary, North Carolina accredited by Crixeo Health?

Cary, North Carolina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cary, North Carolina?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.